5 completed, 4 recruiting, 1 not yet recruiting, 1 unknown. 3 Not applicable, 2 Phase 2, 2 Phase 3, 2 Phase 4, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 2, Unknown 1 |
| Phase 2 | 2 | Not yet recruiting 1, Recruiting 1 |
| Phase 3 | 2 | Completed 2 |
| Phase 4 | 2 | Recruiting 2 |
| Phase 1 | 1 | Recruiting 1 |
Follow Papillomavirus Infection: new trials by email Literature Review of Papillomavirus Infection trials Research Report on Papillomavirus Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination Bevacizumab and PRGN-2012 in Adults With Recurrent Respiratory Papillomatosis (RRP) PRGN-2012, Bevacizumab - Respiratory Recurrent Papillomatosis (RRP), Human Papillomavirus (HPV) | Phase 2 | Not yet recruiting | National Cancer Institute (NCI) | 50 | 2026-11-01 | 2026-10-27 |
| Impact of an e-Bug Educational Intervention on HPV Vaccine Uptake in Middle School Students Consent for HPV vaccination - Papillomavirus Infection, Papillomavirus Vaccines | Recruiting | Centre Hospitalier Universitaire de Nice | 11000 | 2025-05-01 | 2025-12-05 | |
| Zopa Retreatment and Vector Shedding in Adults With RRP Zopapogene imadenovec (Zopa) - Recurrent Respiratory Papillomatosis, Papillomavirus Infection | Phase 4 | Recruiting | Precigen, Inc | 30 | 2024-07-11 | 2025-12-15 |
| Acceptability of Human Papillomavirus Self-sampling in Women Living With HIV HPV self-sampling - Papillomavirus Infection | Not applicable | Unknown | Assistance Publique - Hôpitaux de Paris | 200 | 2023-05-01 | 2023-04-12 |
| HPV Self-Sampling in Somali Women (Isbaar Project) COPAN 552c.80 FLOQSwab - Cervical Cancer, Papillomavirus Infection | Not applicable | Completed | University of Minnesota | 3367 | 2023-02-20 | 2025-07-10 |
| A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors STAR0602, Irinotecan (Camptosar), Docetaxel (Taxotere) - Advanced Solid Tumors, Genital Neoplasm, Female | Phase 1 / Phase 2 | Recruiting | Marengo Therapeutics, Inc. | 366 | 2023-01-04 | 2026-08-11 |
| Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV Human papillomavirus 9-valent vaccine, recombinant, human papillomavirus vaccine, recombinant - Papillomavirus Vaccines, Human Immunodeficiency Virus | Phase 4 | Recruiting | Louisiana State University Health Sciences Center in New Orleans | 250 | 2022-11-30 | 2025-04-18 |
| HPV Prevalence in Transpersons - a Prospective Study Colli-Pee urine collection device, Survey - Papillomavirus Infection, Transsexualism | Not applicable | Completed | Sophie Pils | 203 | 2021-05-02 | 2023-03-15 |
| Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting Vaccination Program - Influenza Vaccine, Papillomavirus Infection | Completed | Duke University | 3988 | 2008-11-01 | 2012-10-16 | |
| Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine GSK Biologicals' HPV-16/18 Vaccine (Cervarix™), Havrix™ - Cervical Intraepithelial Neoplasia, Papillomavirus Infection | Phase 3 | Completed | GlaxoSmithKline | 1245 | 2005-10-01 | 2012-09-18 |
| A Study to Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501, qHPV) in Mid-Adult Women (V501-019) Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine, Comparator: Placebo - Healthy Adult Female Participants, Prevention | Phase 3 | Completed | Merck Sharp & Dohme LLC | 3819 | 2004-06-16 | 2017-04-21 |
Papillomavirus Infections (11) · Recurrent respiratory papillomatosis (2) · Uterine Cervical Dysplasia (2) · Uterine Cervical Neoplasms (2) · Abdominal Neoplasms (1) · Acquired Immunodeficiency Syndrome (1) · Biliary Tract Neoplasms (1) · Carcinoma (1) · Carcinoma, Basal Cell (1) · Carcinoma, Merkel Cell (1) · Carcinoma, Non-Small-Cell Lung (1) · Colorectal Neoplasms (1) · DNA Virus Infections (1) · Endometrial Neoplasms (1) · Epstein-Barr Virus Infections (1)
Communicable Diseases (11) · Disease Attributes (11) · Genital Diseases (11) · Pathologic Processes (11) · Pathological Conditions, Signs and Symptoms (11) · Sexually Transmitted Diseases (11) · Sexually Transmitted Diseases, Viral (11) · Urogenital Diseases (11) · DNA Virus Infections (10) · Infections (10) · Tumor Virus Infections (10) · Virus Diseases (10) · Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Genital Diseases, Female (4)
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (2) · Bevacizumab (1) · Consent Forms (1) · Docetaxel (1) · Hepatitis A Vaccines (1) · Human Papillomavirus Recombinant Vaccine nonavalent (1) · Irinotecan (1) · Papillomavirus Vaccines (1) · Surveys and Questionnaires (1) · human papillomavirus vaccine, L1 type 16, 18 (1)
Assistance Publique - Hôpitaux de Paris (1) · Centre Hospitalier Universitaire de Nice (1) · Duke University (1) · GlaxoSmithKline (1) · Louisiana State University Health Sciences Center in New Orleans (1) · Marengo Therapeutics, Inc. (1) · Merck Sharp & Dohme LLC (1) · National Cancer Institute (NCI) (1) · Precigen, Inc (1) · Sophie Pils (1) · University of Minnesota (1)
United States (6) · France (3) · Austria (1) · Canada (1) · Colombia (1) · Germany (1) · Honduras (1) · Panama (1) · Slovenia (1) · Spain (1) · Taiwan (1)
Amy Lankford, PhD (1) · Elmar Joura, MD (1) · Geeta Swamy, MD (1) · Jennifer E Cameron, PhD (1) · Michael E Hagensee, MD, PhD (1) · Rachel Winer, PhD (1) · Rebekah Pratt, PhD (1) · Scott M Norberg, D.O. (1)
PMID 19493565, PMID 19652630, PMID 19935017, PMID 21629249, PMID 22265115, PMID 22518014, PMID 24391768, PMID 29074187, PMID 32184277, PMID 36263396, PMID 39561921, PMID 41410863
2023 (1)